Momenta Pharmaceuticals Inc. (MNTA)

14.58 +0.05 (+0.344%)

IEX Real-Time Price

March 19, 2019 EST.

Nasdaq Global Select : Healthcare

Prev Close 14.53

Price Open 14.55

Volume: 405,570

Avg Volume: 674,922

Market Cap: 1.44B

P/E Ratio -7.08

52 Wk Range 9.55-32.2



MNTA Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
74.07M
2.86M
3.75
3.86%

2018-09-28
74.07M
3.41M
7.64
4.60%

2018-09-14
74.07M
4.13M
11.26
5.58%

2018-08-31
74.07M
3.69M
9.72
4.99%




MNTA Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2019-02-22
Q4 2018
BTO
-0.46 (3)
-0.07
0.39

2018-11-07
Q3 2018
BTO
-0.63 (2)
-0.45
0.18

2018-08-09
Q2 2018
BTO
-0.46 (1)
-0.91
-0.45

2018-05-08
Q1 2018
BTO
0.00 (0)
-0.63
0.00

News

BTIG likes Arcus Bio in premarket analyst action (2019-03-18 08:51 SeekingAlpha)

Momenta Pharmaceuticals (NASDAQ: MNTA ) initiated with Neutral rating at BTIG Research. More news on: Momenta Pharmaceuticals, Inc., Arcus Biosciences, Inc., Exelixis, Inc., Healthcare stocks news, Stocks on the move, , Read more …

 


Statistics

Shares Outstanding: 98.51M

Top 15 Institution Percent: 156.10

Price To Sales: 18.94

Price To Book: 3.10

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -35.53

Return On Equity: -42.16

Profit Margin: N/A

Price History

Beta: 2.24

50-day Moving Avg: 12.74

200-day Moving Avg: 18.75

YTD Change: 29.03

5-day Change: 2.75

1-month Change: 3.77

3-month Change: 30.65

6-month Change: -46.50

1-year Change: -20.11

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Momenta Pharmaceuticals Inc.

Exchange: Nasdaq Global Select

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.momentapharma.com

Momenta Pharmaceuticals Inc is a biotechnology company. It is engaged in developing generic versions of complex drugs, biosimilars and novel therapeutics for oncology and autoimmune disease.